STING1 and cancer: After 12–18 Gy irradiation, DNA exonuclease Trex1 is produced in different cancer cells, which degrades cytoplasmic DNA, leading to the reduction of dsDNA required for cGAS/STING activation and inhibiting the antitumor immune effect.66